Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Nebcinal vs Tobi in Cystic Fibrosis
NCT01337219Phase 2Unknown
- Sponsor
- Erempharma
- Start
- Apr 2011
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tobramycin in cystic fibrosis (CF), sponsored by Erempharma. Status: unknown.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01337219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01337219.